Cite
HARVARD Citation
Doz, F. et al. (2022). Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Neuro-oncology. 24 (6), pp. 997-1007. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Doz, F. et al. (2022). Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Neuro-oncology. 24 (6), pp. 997-1007. [Online].